Trials / Completed
CompletedNCT00215709
Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer
A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Geriatric Oncology Consortium · Academic / Other
- Sex
- Male
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study is designed to determine the feasibility and safety of administering docetaxel at various dosing levels on a bi-weekly schedule in older men with hormone refractory prostate cancer.
Detailed description
The information obtained from this trial will help determine the feasibility and safety of administering docetaxel at various dosing levels on a bi-weekly schedule in this patient population. If the data from this phase I trial are encouraging, a phase II trial will be conducted to further assess the efficacy of this dosing schedule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | docetaxel |
Timeline
- Start date
- 2004-07-01
- Completion
- 2007-07-01
- First posted
- 2005-09-22
- Last updated
- 2007-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00215709. Inclusion in this directory is not an endorsement.